Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a nurse and an app improve life after gynecologic cancer?

NCT ID NCT04122235

Symptom relief Sponsor: Sorlandet Hospital HF Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new way to follow up with gynecologic cancer survivors. Instead of seeing a doctor every time, patients saw a nurse at every other visit and used a smartphone app to help manage their health. The goal was to see if this approach improved self-management skills and quality of life. Over 750 women with ovarian, endometrial, cervical, or vulvar cancer took part after finishing their main treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse-led follow-up and a smartphone app (LETSGO-app)
What this could lead to
If successful, this approach could improve how gynecologic cancer survivors manage their health and well-being after treatment.
What could go wrong
This is a completed study comparing follow-up models, not testing a new drug. The results may show only modest benefits, and the app-based approach may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

755 people

The number who actually took part.

Started

Nov 2019

Finished

Mar 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically verified gynaecological cancer 1. Cervical cancer restricted to squameous cell carcinoma, adeno carcinoma and adeno-squameous carcinoma) or 2. Endometrial cancer or 3. Ovarian cancer (restricted to epithelial type) or 4. Vulvar cancer * Must have completed primary treatment and scheduled to follow-up Exclusion Criteria: * Participating in other cancer treatment trial or follow-up trial * Cervical cancer patients treated with trachelectomy * On maintenance therapy * Dementia or other mental/cognitive impairment * Illiterate in Norwegian

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease cervical cancer Empowerment endometrial cancer endometrium neoplasm female reproductive organ cancer female reproductive system neoplasm ovarian cancer Uterine Cervical Neoplasms vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer Endometrial cancer Gynecologic cancer Gynecologic neoplasm Ovarian cancer Vulvar cancer

Contacts and locations

Locations

  • Akershus University Hospital

    Lørenskog, Norway

  • Innlandet Hospital Gjøvik

    Gjøvik, Oppland, 2819, Norway

  • Innlandet Hospital Lillehammer

    Lillehammer, 2609, Norway

  • Nordland Hospital

    Bodø, Norway

  • Oslo University Hospital

    Oslo, Norway

  • Sorlandet Hospital

    Kristiansand, Vest Agder, 4604, Norway

  • St.Olavs Hospital

    Trondheim, Norway

  • Stavanger University Hospital

    Stavanger, Norway

  • Sørlandet hospital Arendal

    Arendal, Norway

  • University Hospital of North Norway

    Tromsø, Norway

  • Vestfold Hospital Trust

    Tønsberg, Norway

  • Østfold Hospital Trust

    Sarpsborg, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.